🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
18,54 USD
Máx. histórico
178,74
2142 días
Split 1:6 del 12/07/2012
Caída desde máximo
-89,63%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,20%
Cierre anterior
18,32
Rango de hoy
18,29 – 18,81
Volumen hoy
1.397.929
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,44%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 10 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/03/2025 | 100,25 | 103,59 | 99,50 | 102,86 | +1,62% | 4,08% | 1.197.200 |
| 03/03/2025 | 106,75 | 107,35 | 100,15 | 101,22 | -5,18% | 6,74% | 1.355.500 |
| 28/02/2025 | 104,21 | 108,48 | 103,46 | 106,75 | +3,58% | 4,82% | 1.279.900 |
| 27/02/2025 | 101,00 | 109,50 | 101,00 | 103,06 | -3,56% | 8,42% | 1.589.400 |
| 26/02/2025 | 106,88 | 109,55 | 106,37 | 106,86 | -0,08% | 2,98% | 1.077.800 |
| 25/02/2025 | 105,75 | 107,11 | 103,33 | 106,95 | +1,32% | 3,57% | 1.069.500 |
| 24/02/2025 | 105,49 | 107,54 | 105,47 | 105,56 | -0,68% | 1,96% | 741.500 |
| 21/02/2025 | 109,50 | 110,00 | 106,02 | 106,28 | -1,96% | 3,63% | 709.300 |
| 20/02/2025 | 107,30 | 109,83 | 105,93 | 108,41 | +1,20% | 3,63% | 836.100 |
| 19/02/2025 | 105,96 | 107,46 | 104,74 | 107,12 | +1,68% | 2,57% | 713.500 |
| 18/02/2025 | 102,60 | 106,10 | 101,15 | 105,35 | -2,41% | 4,82% | 1.307.000 |
| 14/02/2025 | 109,84 | 111,21 | 107,61 | 107,95 | -1,38% | 3,28% | 630.800 |
| 13/02/2025 | 109,40 | 110,11 | 107,74 | 109,46 | -0,32% | 2,17% | 712.600 |
| 12/02/2025 | 109,00 | 110,34 | 108,17 | 109,81 | +0,12% | 1,99% | 639.500 |
| 11/02/2025 | 110,52 | 111,59 | 109,55 | 109,68 | -2,71% | 1,85% | 654.200 |
| 10/02/2025 | 112,00 | 114,41 | 110,81 | 112,74 | +0,82% | 3,21% | 604.100 |
| 07/02/2025 | 112,00 | 112,37 | 109,52 | 111,82 | -0,26% | 2,54% | 881.400 |
| 06/02/2025 | 118,78 | 119,27 | 112,06 | 112,11 | -5,81% | 6,07% | 886.400 |
| 05/02/2025 | 114,71 | 120,05 | 114,46 | 119,02 | +4,33% | 4,87% | 842.400 |
| 04/02/2025 | 113,14 | 115,12 | 112,87 | 114,08 | +0,24% | 1,99% | 563.600 |
| 03/02/2025 | 111,48 | 114,80 | 111,48 | 113,81 | +0,08% | 2,98% | 604.300 |
| 31/01/2025 | 114,87 | 116,15 | 112,78 | 113,72 | -0,64% | 2,93% | 724.600 |
| 30/01/2025 | 115,53 | 116,24 | 113,46 | 114,45 | -0,87% | 2,41% | 767.900 |
| 29/01/2025 | 117,24 | 117,50 | 113,38 | 115,45 | -1,75% | 3,51% | 907.000 |
| 28/01/2025 | 117,12 | 118,28 | 116,54 | 117,51 | +0,53% | 1,49% | 1.220.600 |
| 27/01/2025 | 116,47 | 119,44 | 116,31 | 116,89 | +0,37% | 2,69% | 858.000 |
| 24/01/2025 | 118,95 | 119,00 | 116,00 | 116,46 | -2,25% | 2,52% | 1.126.200 |
| 23/01/2025 | 116,09 | 120,00 | 114,06 | 119,14 | +2,63% | 5,12% | 794.800 |
| 22/01/2025 | 117,00 | 118,20 | 115,50 | 116,09 | -0,60% | 2,31% | 731.700 |
| 21/01/2025 | 118,53 | 119,51 | 116,21 | 116,79 | -1,03% | 2,78% | 1.198.300 |